Industry litigation – Page 22
-
Business
Monsanto wins $1bn in patent case
Monsanto had claimed that DuPont infringed its patents covering glyphosate pesticide products
-
Business
China to investigate polysilicon imports
An ongoing international row over the market for solar panels is spilling over into the supply chain
-
BusinessObesity drug approved in US
Qsymia from Vivus joins Belviq in a lucrative part of the pharma industry
-
BusinessInterview: EMA head Guido Rasi
Guido Rasi, head of the European Medicines Agency, wants to see greater transparency in drug development
-
Business$3bn GSK fine sets new industry record
The fine relates to off label marketing and is the largest payment of its kind ever made by a drug company
-
Business
Roche rapped for side-effect reporting failure
European medicines regulator names and shames Swiss giant for not disclosing 80,000 instances of potential adverse drug reactions
-
Business
Nasonex patent ruling goes against Merck & Co
The court ruled that the Merck patent was valid - but Apotex won’t infringe it with its product
-
BusinessDrug watchdogs mark out global territory
US and European regulatory agencies are leading worldwide collaborations to ensure drugs from outside their borders are safe
-
Business
Seroquel patent row continues
The legal tug of war over the right to sell generic versions of Seroquel (quetiapine) tablets continues
-
Business
Court throws out patent covering drug dosing
The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented